미국 - 영어 - NLM (National Library of Medicine)

elanco us inc. - deracoxib (unii: vx29jb5xwv) (deracoxib - unii:vx29jb5xwv) - deracoxib 12 mg - always provide “information for dog owners” sheet with prescription. carefully consider the potential benefits and risk of deramaxx and other treatment options before deciding to use deramaxx. use the lowest effective dose for the shortest duration consistent with individual response. osteoarthritis pain and inflammation: deramaxx chewable tablets are indicated for the control of pain and inflammation associated with osteoarthritis in dogs. dogs with known hypersensitivity to deracoxib should not receive deramaxx.

미국 - 영어 - NLM (National Library of Medicine)

bluepoint laboratories - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium 50 mg - diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in adult patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications [see warnings and precautions (5.3)]. diclofenac sodium and misoprostol delayed-release tablets are contraindicated in the following patients: - pregnancy. use of misoprostol, a component of diclofenac sodium and misoprostol delayed-release tablets, during pregnancy can result in maternal and fetal harm, including uterine rupture, abortion, premature birth, or birth defects [see warnings and precautions (5.1) and use in specific populations (8.1)] - in the setting of coronary artery bypa

미국 - 영어 - NLM (National Library of Medicine)

cardinal health - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 100 mg - celebrex is indicated for the management of the signs and symptoms of oa [see clinical studies (14.1) ] for the management of the signs and symptoms of ra [see clinical studies (14.2) ] for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ] for the management of the signs and symptoms of as [see clinical studies (14.4) ] for the management of acute pain in adults [see clinical studies (14.5) ] for the management of primary dysmenorrhea [see clinical studies (14.5) ] celebrex is contraindicated in the following patients: pregnancy category c. pregnancy category d from 30 weeks of gestation onward. risk summary use of nsaids, including celebrex, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including celebrex, in pregnant women starting at 30 weeks of gestation. there are no adequate and well-controlled studies of celebrex in pregnant women. data from observational stu

미국 - 영어 - NLM (National Library of Medicine)

remedyrepack inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg

미국 - 영어 - NLM (National Library of Medicine)

greenstone llc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium 50 mg - diclofenac sodium/misoprostol is indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in adult patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications [see warnings and precautions (5.3)] . diclofenac sodium/misoprostol is contraindicated in the following patients: risk summary diclofenac sodium/misoprostol is contraindicated in pregnant women [see contraindications (4)] . if a woman becomes pregnant while taking diclofenac sodium/misoprostol, discontinue the drug and advise the woman of the potential risks to her and to a fetus. there are no adequate and well-controlled studies of diclofenac sodium/misoprostol in pregnant women; however, there is information available about the active drug components of diclofenac sodium/misoprostol, diclofenac sodium and misoprostol. administration of misoprostol to pregnan

미국 - 영어 - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - ciclopirox (unii: 19w019zdrj) (ciclopirox - unii:19w019zdrj) - ciclopirox 7.70 mg in 1 g - superficial dermotophyte infections - ciclopirox gel 0.77% is indicated for the topical treatment of interdigital tinea pedis and tinea corporis due to trichophyton   rubrum , trichophyton   mentagrophytes , epidermophyton   floccosum . seborrheic dermatitis - ciclopirox gel 0.77% is indicated for the topical treatment of seborrheic dermatitis of the scalp. ciclopirox gel 0.77% is contraindicated in individuals who have shown hypersensitivity to any of its components.

미국 - 영어 - NLM (National Library of Medicine)

physicians total care, inc. - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - ketorolac tromethamine 5 mg in 1 ml - ketorolac tromethamine ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis.  ketorolac tromethamine ophthalmic solution is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction. ketorolac tromethamine ophthalmic solution is contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formulation.

캐나다 - 영어 - Health Canada

accel pharma inc - celecoxib - capsule - 100mg - celecoxib 100mg - cyclooxygenase-2 (cox-2) inhibitors

캐나다 - 영어 - Health Canada

accel pharma inc - celecoxib - capsule - 200mg - celecoxib 200mg - cyclooxygenase-2 (cox-2) inhibitors

캐나다 - 영어 - Health Canada

ranbaxy pharmaceuticals canada inc. - celecoxib - capsule - 100mg - celecoxib 100mg - cyclooxygenase-2 (cox-2) inhibitors